These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 18419389

  • 1. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J, Schmid DS, Gershon AA.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A.
    Clin Infect Dis; 2002 Mar 15; 34(6):774-9. PubMed ID: 11830801
    [Abstract] [Full Text] [Related]

  • 4. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T, Kamada M, Igarashi C, Yuri K, Furukawa H, Chiba S, Kojima H, Saito A, Okui T, Yano S.
    J Infect Dis; 1999 Sep 15; 180(3):834-7. PubMed ID: 10438374
    [Abstract] [Full Text] [Related]

  • 5. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K, Niizuma T, Yagi Y, Miyashima H, Kataoka N, Sadahiro T.
    J Med Virol; 2000 Sep 15; 62(1):46-51. PubMed ID: 10935988
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ.
    Pediatr Infect Dis J; 2007 Jul 15; 26(7):572-6. PubMed ID: 17596796
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [Abstract] [Full Text] [Related]

  • 11. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R, Luescher D, Just M.
    Postgrad Med J; 1985 Mar 01; 61 Suppl 4():143-5. PubMed ID: 3014472
    [Abstract] [Full Text] [Related]

  • 12. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ, Brisson M.
    J Infect; 2002 May 01; 44(4):211-9. PubMed ID: 12099726
    [Abstract] [Full Text] [Related]

  • 13. Varicella immunity: persistent serologic non-response to immunization.
    Katial RK, Ratto-Kim S, Sitz KV, Moriarity R, Engler RJ.
    Ann Allergy Asthma Immunol; 1999 May 01; 82(5):431-4. PubMed ID: 10353572
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF, Li CK, Hung EC, Chan PK, Mo CW, Wong RP, Chik KW.
    Eur J Haematol; 2004 May 01; 72(5):353-7. PubMed ID: 15059071
    [Abstract] [Full Text] [Related]

  • 15. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC, Klein S, Baiker A, Wirth S, Sander M, Noelting C, Boecher O, Vizoso-Pinto MG.
    Pediatr Infect Dis J; 2012 Nov 01; 31(11):1148-52. PubMed ID: 22863912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L, LaRussa P, Steinberg SP, Zhou J, Baron K, Whittier S, Della-Latta P, Gershon AA.
    Infect Control Hosp Epidemiol; 2001 May 01; 22(5):279-83. PubMed ID: 11428437
    [Abstract] [Full Text] [Related]

  • 18. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I, Balicer RD, Smetana Z, Davidovitch N, Bar-Zeev Y, Mendelson E, Zarka S, Huerta M.
    Infection; 2008 Mar 01; 36(2):130-4. PubMed ID: 18379727
    [Abstract] [Full Text] [Related]

  • 19. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
    Chris Maple PA, Gray J, Brown K, Brown D.
    J Virol Methods; 2009 Apr 01; 157(1):90-2. PubMed ID: 19135089
    [Abstract] [Full Text] [Related]

  • 20. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I, Study Group for Varivax.
    Pediatr Infect Dis J; 2004 Feb 01; 23(2):132-7. PubMed ID: 14872179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.